BioDiscovery, N-of-One Ink Marketing Deal for Genomic Analysis Solutions | GenomeWeb

NEW YORK (GenomeWeb News) – BioDiscovery and N-of-One today announced a marketing agreement to provide genomic analysis interpretation solutions.

The companies will jointly market and sell N-of-One's interpretation solutions and content with BioDiscovery's genomic analysis software. The deal, they said, will allow clinicians to use genomic data more easily and efficiently to identify targeted therapies that are most appropriate for each individual patient and to better understand the molecular profile of the patient's tumor.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.